LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Company will be presenting at Susquehanna's SIGnificant Options in Healthcare Conference on Tuesday, March 4, 2008 at 9:30 am (ET) at the W Hotel in New York.
